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Singapore is a small city state located approximately 1° above the
equator. The population of approximately 3 million citizens is
comprised of three main ethnic groups; the Chinese who comprise
some 77% of the population, the Malays, who comprise some 14%
of the population and the Indians who comprise approximately 7%
of the population. Each of these races has significantly different
age-standardized rates of colorectal cancer (see Table 1), with the
Chinese citizens having a 2–2.5-fold higher risk of getting colorectal
cancer than their Indian or Malay neighbours (Chia et al, 1996).
The incidence of colorectal cancer throughout the population
has been rising steadily. In 1972, the end of the first 5-year period
in which comprehensive national cancer records were kept, the
age-standardized rates of colorectal cancer were 19.9 per 100 000
for males and 15.6 per 100 000 for females. Colorectal cancer was
the fourth most common cancer in males, and the fifth most
common cancer in females. Today the situation is markedly
different, and the records for the period 1988–1992, the latest for
which records have been published, colorectal cancer incidence is
36.4 and 28.5 per 100 000 for males and females respectively, and
ranks as the second most common cancer for both males and
females (Chia et al, 1996). As such, Singapore offers unique
opportunities to study the molecular events in tumorigenesis, both
with respect to a single population that is undergoing a rapid
increase in incidence of colorectal cancer, as well as by compar-
isons between population groups who essentially experience the
same social and living conditions, but have markedly different
rates of colorectal cancer.
Colorectal cancer is believed to arise by the accumulation of
genetic damage, in a process that may take years, or potentially
decades (Fearon and Vogelstein, 1990; Fearon and Jones, 1992).
Many of these changes have been well documented, and can
include activation of oncogenes as well as the inactivation of
tumour suppressor genes and genes of the mismatch repair family
of genes (Baba, 1997).
Approximately 40% of colorectal adenocarcinomas have been
shown to contain activated copies of the c-Ki-ras proto-oncogene
(Breivik et al, 1994; Kiaris and Spandidos, 1995; Elnatan et al,
1996) This gene belongs to the ras family of proto-oncogenes,
three closely related genes that code for proteins 188 or 189 amino
acids long (Barbacid, 1987; Bos, 1989; Grand and Owen, 1991),
which exhïbit intrinsic GTPase activity (Grand and Owen, 1991).
All members of the ras family are converted to active oncogenes
in naturally occurring tumours by point mutations in codons 12, 13
or 61 (Barbacid, 1987), although there is a strong preference for
mutations in codons 12 or 13 (Bos, 1989; Yanez et al, 1987). These
mutations abolish GTPase activity, and result in constitutive
stimulation of autonomous growth and contribute to neoplastic
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Table 1 Age-standardized rates of colorectal cancer in Singapore
1968–1972 1988–1992
Males Females Males Females
Chinese 22.2 16.6 42.2 31.2
Malay 8.6 6.0 19.1 14.3
Indian 10.7 9.0 13.6 11.3
Population 19.9 15.6 36.4 28.5
Age-standardised rates for colorectal cancer by sex and race for time periods
1968–1972 and 1988–1992 (adapted from Chia et al, 1996)
© 1999 Cancer Research Campaigndevelopment (Barbacid, 1987; Bos, 1989; Grand and Owen,
1991).
The particular member of the ras gene family that is found to be
activated is characteristic of a particular tumour type, and in
colorectal adenocarcinomas the majority of ras activation is asso-
ciated with c-Ki-ras (Bos et al, 1987). Activation of the c-Ki-ras
gene has been found to be associated with a number of factors such
as patient age, sex and tumour location (Breivik et al, 1994;
Elnatan et al, 1996), and the presence of mutations has been
variously correlated with neoplastic progression (Vogelstein et al,
1988; Fearon and Vogelstein, 1990; Fearon and Jones, 1992),
pattern of disease dissemination (Finkelstein et al, 1993a, 1993b)
and patient survival (Elnatan et al, 1996; Smith et al, 1996).
We were interested to discover whether the rate of c-Ki-ras
mutation was constant in a single population that had experienced
colorectal cancer as both a high incidence and a low incidence
disease within the span of a single generation, and to possibly
determine whether the spectrum of mutations in the c-Ki-ras gene
had undergone significant alterations. To undertake this we
analysed tumours harvested some 30–35 years ago in parallel with
tumours collected from contemporary patients. Results showed
that the mutation rates are significantly different between the two
cohorts, and for the first time offering a potential link between the
increase in the incidence of colorectal cancer seen in Singapore
and a specific genetic change.
MATERIALS AND METHODS
Patients and tumours
Tumours analysed were from patients undergoing colonic resec-
tion for colorectal adenocarcinoma either during the period
1962–1966 or during the period 1994–1996. Tumours from the
contemporary period were collected along with matched normal
mucosa from the same patient and stored at –80°C until analysed.
Tumours from the period 1962–1966 were obtained as several
contiguous 10-mm sections from paraffin blocks histologically
verified to contain colorectal adenocarcinoma.
DNA preparation, PCR and DNA sequencing
Genomic DNA was extracted from tumour samples containing at
least 70% neoplastic cells, as assessed histochemically, along with
genomic DNA from matched normal mucosa from the same
patient as described previously (Khine et al, 1994). Genomic DNA
was prepared from archival paraffin sections using the Prep-A-
Gene (BioRad, Hercules, CA, USA) protocol of Wang et al (1994).
A 176-bp fragment of exon 1 of the c-Ki-ras gene was amplified
from all DNA samples using custom synthesized oligonucleotides
5¢-CATGTTCTAATATAGTCACA-3¢ (forward); and 5¢-AACAA-
GAATTACCTCTATTG-3¢ (reverse) essentially as described
previously (Elnatan et al, 1996; Smith et al, 1996). Polymerase
chain reactions (PCR) were as previously described (Elnatan et al,
1996; Smith et al, 1996), with the modification that to equalize
yields of amplicon from the two source of starting material,
archival samples were subjected to 40 cycles while fresh, flash-
frozen materials (tumour and mucosa) were subjected to 30 cycles.
For DNA sequencing the PCR products were purified by
agarose gel electrophoresis and excised from the gel matrix after
which templates were purified using the Qiaex PCR Purification
Kit (Qiagen, Hilden, Germany). DNA sequencing reactions were
performed using the Big Dye Termination reaction kit (PE Applied
Biosystems, Foster City, CA, USA) on approximately 60–90 ng of
template from above. Analysis was undertaken on an automated
ABI 377-18 DNA Sequencer (PE Applied Biosystems).
Mismatch-specific oligonucleotide hybridization
Mismatch-specific oligonucleotide hybridization was performed
essentially as described by Verlaan de Vries et al (1986) with some
modifications as described previously (Elnatan et al, 1996; Smith
et al, 1996) using a panel of primers specific for all possible muta-
tions of the c-Ki-ras proto-oncogene in codons 12 and 13 (Human
ras Muta-Lyzer Probe Panels, Clontech Laboratories Inc., Palo
Alto, CA, USA).
RESULTS
A total of 68 colorectal adenocarcinomas were examined for muta-
tion of the c-Ki-ras proto-oncogene. Eighteen of these samples
were archival paraffin sections obtained from formalin-treated,
paraffin-embedded blocks of tumour biopsy samples collected
from patients operated on between 1962 and 1966. The remaining
50 samples were from patients operated on during the period
1992–1994 and kept as fresh, flash-frozen specimens, along with
their matched normal mucosa until required for analysis. No statis-
tically significant difference was found between the two cohorts
with respect to patient age, sex, race, tumour location and stage
(Table 2). All tumour samples were histologically confirmed to
contain at least 70% tumour cells.
Genomic DNA was extracted from contemporary tumour
samples in parallel with genomic DNA from matched normal
mucosa of the same patient by standard methodologies (Khine et
al, 1994). Several methodologies were attempted for extraction of
genomic DNA by archival samples, with consistent results being
238 W-Y Tang et al
British Journal of Cancer (1999) 81(2), 237–241 © 1999 Cancer Research Campaign
Table 2 Clinical data for archival (1962–1966) and contemporary
(1994–1996) colorectal adenocarcinoma samples
Contemporary Archival Significance
samples samples
Sex
Male 33 13
Female 17 5 NS (P = 0.62)
Age
Mean (±SD) 62.4 ± 14.9 56.5 ± 11.6 NS (P = 0.13)
Range 25–91 35–76
Location
Proximal 16 5
Distal 34 13 NS (P = 0.73)
Stage
A7 2
B 15 10 NS (P = 0.14)
C2 8 6
Race
Chinese 44 15 NS (P = 0.61)
Others 6 3
The two cohorts are not significantly different in composition with respect to
sex (Fisher’s exact test), age (ANOVA), tumour location (Fisher’s exact test),
race (Fisher’s exact test) and stage (c2 test). Tumours are staged as (A)
tumour within intestinal wall; (B) tumour extends beyond serosa, no lymph
node involvement and (C) lymph node metastasis. NS, not significant.obtained by the Prep-A-Gene methodology of Wang et al (1994;
data not shown). Exon 1 of the c-Ki-ras gene was amplified by
PCR, and samples dotted onto nylon support membranes. All
samples were analysed for mutations occurring in codon 12 and 13
of c-Ki-ras by mismatch-specific oligonucleotide hybridization
(Verlaan de Vries et al, 1986). Control hybridizations for both
codon 12 and 13 wild-type sequences were also carried out
(Figures 1 and 2).
Sixteen mutants were detected in 14 samples (two tumours
contained two mutant codons) from the contemporary cohort.
Hence 28% of samples were mutated (14/50) and 8% (16/200) of
codons. Ninety-three per cent (15/16) of the mutations occurred in
codon 12 and 7% (1/16) in codon 13 (Figure 2). Both the
frequency of the c-Ki-ras mutation and the distribution of mutants
(Table 3) were consistent with our previously published results on
c-Ki-ras gene mutations in the local Singaporean population
(Elnatan et al, 1996).
In contrast, archival samples from 1962 to 1966 showed no
evidence of mutation in any sample, a rate statistically different
from that found in the contemporary cohort both with respect to
the number of tumours bearing ras mutations (Samples
1992–1994: 28% [14/50]; Samples 1962–1966 0% [0/18]; P =
0.007, Fisher’s exact test) and to the number of codons (codons
1992–1994: 8% [16/200]; codons 1962–1996 0% [0/72]; P =
0.008, Fisher’s exact test). Probes for wild-type codon 12 and 13
both gave normal level signals (Figure 2). To further confirm the
identity of the PCR product from the archival samples, samples
were also analysed by DNA sequencing using an automated DNA
sequencer. Sequencing analysis confirmed the identity of the
product as being exon 1 of the c-Ki-ras gene (Figure 3).
DISCUSSION
In this study we have reported a statistically different rate of c-Ki-
ras mutation in samples of colorectal adenocarcinomas harvested
30–35 years ago to the rate of mutation detected in contemporary
samples. Indeed, we were unable to detect any cases of c-Ki-ras
mutation in the archival samples. This result was somewhat
surprising. The c-Ki-ras proto-oncogene is currently found
mutated in 20–40% of colorectal adenocarcinomas, dependent
upon factors including the age and sex of the patient as well as the
location of the tumour (Breivik et al, 1994; Elnatan et al, 1996),
and c-Ki-ras activation is believed to play a significant role in
tumorigenesis, possibly being involved in the transition from
adenoma to carcinoma (Fearon and Vogelstein, 1990; Fearon and
Jones, 1992). Our own data have shown a significant association
between c-Ki-ras activation and tumour progression in tumours
originating on the left of the colorectum and an association with a
poorer prognosis (Elnatan et al, 1996).
However, recently several lines of evidence have suggested that
ras activation may not be causally involved in tumour progression.
In particular the findings that ras activation can be detected in
phenotypically normal tissues (Keohavong et al, 1997; Zhu et al,
1997), and in small non-dysplastic lesions of low tumorigenic
potential (Jen et al, 1994) as well as the observation that activated
ras genes are present in tumour cells at levels approximately 100-
fold less than that required to induce transformation in cell lines
(Hua et al, 1997). These findings, coupled with those that show
that ras activation is actually higher in aberrant crypt foci (Otori et
al, 1995; Yamashita et al, 1995a, 1995b) – the purported precursor
to adenomas – than in developed adenocarcinomas suggest that ras
activation may simply reflect the mutational burden of a tumour,
rather that being specifically involved in the tumorigenic process.
We have previously shown that both p53 point mutation (Goh et
al, 1995) and c-Ki-ras point mutation (Elnatan et al, 1996) are
significantly associated with a poorer patient prognosis in tumours
originating in tumours on the left of the colorectum. Perhaps more
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Figure 1 Representative c-Ki-ras mismatch-specific oligonucleotide
hybridization analysis of seven archival (> 30 years) colorectal
adenocarcinoma specimens. Shown here are results for probes for Gly12
and Gly13 (wild-type sequences). All other probes were negative
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Figure 2 Representative c-Ki-ras mismatch-specific oligonucleotide
hybridization analysis of 12 contemporary colorectal adenocarcinoma
specimens (bottom row: T) together with their normal matched mucosa
harvested from the same patient (top row: M). Results are shown for Gly12
and Gly13 (wild-type sequences), as well as for Val12 and Asp12 (mutated
codons). All other probes were negative in these samples
Table 3 Distribution of c-Ki-ras mutants
Established local Present cohort Present cohort
rates* (contemporary) (archival)
Asp12 7% (14/210) 14% (7/50) 0% (0/18)
Val 12 8% (17/210) 10% (5/50) 0% (0/18)
Cys12 5% (10/210) 2% (1/50) 0% (0/18)
Ser12 2% (4/210) 2% (1/50) 0% (0/18)
Ala12 1.5% (3/210) 2% (1/50) 0% (0/18)
Asp13 5% (11/210) 2% (1/50) 0% (0/18)
Cys13 1.5% (3/210) 0% (0/50) 0% (0/18)
Total 30% (62/210) 32% (16/50) 0% (0/18)
The specific c-Ki-ras mutants in the present cohorts are listed, alongside
previously established c-Ki-ras data for colorectal adenocarcinomas from
Singapore (*Elnatan et al, 1996).interestingly we have also shown that when considering these two
changes together the effect on patient prognosis is additive with
patients showing both p53 and ras mutation showing a poorer
prognosis than patients showing either one of these changes, and
these patients in turn showing a poorer prognosis than patients
who evinced neither of these changes (Smith et al, 1996). In a Cox
regression analysis we noted that the terms for both p53 mutation
and c-Ki-ras mutation were excluded in favour of a term that
simply described the number of changes seen in a tumour (0, 1 or
2). As such, this analysis would seem to indicate that a better idea
of patient prognosis could be determined by obtaining some idea
of mutational burden.
The cause of mutations in the c-Ki-ras proto-oncogene remain
unclear, although some authors have suggested that bile acids may
be implicated in the tumorigenic process (Cohen et al, 1989;
Chaplin, 1998). Other studies have shown that cooked-meat
heterocyclic amines such as 2-amino-3-methylimidazo[4,5-
f]quinoline can induce aberrant crypt foci with a high rate of ras
mutation in animals (Tachino et al, 1995). The observation that the
rate of mutation in tumours originating on the right of the
colorectum is significantly higher than that found in tumours
originating on the left of the colorectum while the spectrum of
mutations detected is similar (Elnatan et al, 1996) is certainly
consistent with a decreasing gradient of mutagen along the length
of the human colorectum. As such c-Ki-ras activation is poten-
tially a ‘fingerprint’ marker of exogenous mutagens.
Many studies have tried to elucidate a relationship between
colorectal cancer and diet and despite the difficulties of these
studies a common consensus would suggest a possible relationship
between consumption of certain foodstuffs and an increased
susceptibility to, or protection from colorectal cancer (World
Cancer Research Fund, 1997). In particular, several studies have
indicated a protective role for cruciferous vegetables such as
cabbage and broccoli (Graham et al, 1978; Haenszel et al, 1980;
Colditz et al, 1985), while other studies have implicated an
increased risk of developing colorectal cancer based on either high
meat consumption (Haenszel et al, 1973; La Vecchia et al, 1988)
or a high meat to vegetable ratio (Manousos et al, 1983; Lee et al,
1989). In Singapore, while there are several studies on recent food
consumption trends (Gourley et al, 1988; Lee et al, 1989), data on
diet 30 years ago are somewhat more scanty. However, what data
there are (Lee and Gourley, 1987) clearly point to a significant
increase in the consumption of meat/offal and oily foods over the
last 30 years. As such the data presented here indicate a somewhat
tenuous link between changing diet, increasing incidence of
colorectal cancer and increasing incidence of c-Ki-ras mutation
suggesting that further studies using old (> 30 years) paraffin
blocks may provide valuable insights into the tumorigenic process.
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